Evidence map›Paper›PMID 32438819›Full record

ArticleAntioxidants & redox signaling2021

Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.

Carlos Sanchez-Martin, Daniela Menon, Elisabetta Moroni, Mariarosaria Ferraro, Ionica Masgras, Justin Elsey, Jack L Arbiser, Giorgio Colombo, Andrea Rasola

Open access · greenAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. TRAP1 and its therapeutic potential.Bioorganic & medicinal chemistry letters · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. TRAP1 in Oxidative Stress and Neurodegeneration.Antioxidants (Basel, Switzerland) · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Carlos Sanchez-MartinDipartimento di Scienze Biomediche, Università di Padova, Padova, Italy.
Daniela MenonDipartimento di Scienze Biomediche, Università di Padova, Padova, Italy.
Elisabetta MoroniIstituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy.
Mariarosaria FerraroIstituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy.
Ionica MasgrasDipartimento di Scienze Biomediche, Università di Padova, Padova, Italy.
Justin ElseyAtlanta Veterans Administration Medical Center, Decatur, Georgia, USA.
Jack L ArbiserAtlanta Veterans Administration Medical Center, Decatur, Georgia, USA.
Giorgio ColomboIstituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy.
Andrea RasolaDipartimento di Scienze Biomediche, Università di Padova, Padova, Italy.
Institute of Chemistry of Molecular Recognition · ITUniversity of Padua · ITEmory University · USNeuroscience Institute · ITUnited States Department of Veterans Affairs · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Allosteric RegulationAllyl CompoundsAntineoplastic AgentsBiphenyl CompoundsCell LineHSP90 Heat-Shock ProteinsHumansLignansMitochondriaModels, MolecularMolecular StructurePhenolsRecombinant ProteinsAllyl CompoundsAntineoplastic AgentsBiphenyl CompoundshonokiolHSP90 Heat-Shock ProteinsLignansPhenolsRecombinant ProteinsTRAP1 protein, humanantineoplastic compoundhonokiolmitochondriamolecular dynamicsneurofibromatosis type 1TRAP1

Identifiers

PMID32438819
PMCPMC8020504
OpenAlexW3028462022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.